Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_assertion type Assertion NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_head.
- NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_provenance.
- NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_assertion evidence source_evidence_literature NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_provenance.
- NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_assertion SIO_000772 19440247 NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_provenance.
- NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_assertion wasDerivedFrom befree-2016 NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_provenance.
- NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_assertion wasGeneratedBy ECO_0000203 NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_provenance.